Pharmacokinetic Modeling of an Induction Regimen for In Vivo Combined Testing of Novel Drugs against Pediatric Acute Lymphoblastic Leukemia Xenografts-Reference-Cited by-同舟云学术

Pharmacokinetic Modeling of an Induction Regimen for In Vivo Combined Testing of Novel Drugs against Pediatric Acute Lymphoblastic Leukemia Xenografts

Published:2012-03-29 Issue:3 Volume:7 Page:e33894
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Szymanska Barbara,Wilczynska-Kalak Urszula,Kang Min H.,Liem Natalia L. M.,Carol Hernan,Boehm Ingrid,Groepper Daniel,Reynolds C. Patrick,Stewart Clinton F.,Lock Richard B.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference53 articles.

1. Recent research advances in childhood acute lymphoblastic leukemia.;CH Pui;J Formos Med Assoc,2010

2. Childhood acute lymphoblastic leukaemia and relapse.;PS Gaynon;Br J Haematol,2005

3. Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.;RH Ko;J Clin Oncol,2010

4. Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia.;JM Chessells;Br J Haematol,2003

5. Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005.;M Arico;J Clin Oncol,2010

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review of L-Asparaginase: Production, Applications and Therapeutic Potential in Cancer Treatment;Applied Biochemistry and Microbiology;2024-06-10

2. The role of quiescent thymic progenitors in TAL/LMO2-induced T-ALL chemotolerance;Leukemia;2024-03-29

3. High CD44 expression identifies rare chemoresistant leukemic cells endowed with enhanced E-Selectin binding in T-ALL;2023-12-20

4. Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia;Science Translational Medicine;2023-05-17

5. STAT5 activation promotes progression and chemotherapy-resistance in early T-cell precursor acute lymphoblastic leukemia;Blood;2023-03-29